Part 1: 2024 NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines to be SCRUBBED on August 16, 2024, Pages 1-250
Special Thanks to Rebecca Charles for Volunteering to Help Put this Together.
The Updated Guidelines
The original NIH page is HERE. This site sends you to their 478-page downloadable PDF, located HERE. This NIH document on Covid treatment guidelines is a comprehensive, 478-paged PDF destined for being removed from the internet tomorrow.
I am doing a combination of images and tables as a hybrid, to preserve the links that the NIH included in the document.
2019 Guidelines
This is the old document. We previously published original guidelines from 2019; it is available a PDF having 359 pages is HERE. It is unknown whether this will also be scraped from the internet. I already split this up into 4 documents:
Part 1: Pages 1-100. https://therebelpatient.substack.com/p/part-1-nih-coronavirus-disease-2019
Part 2: Pages 101-200. https://therebelpatient.substack.com/p/part-2-nih-coronavirus-disease-2019
Part 3: Pages 201-300. https://therebelpatient.substack.com/p/part-3-nih-coronavirus-disease-2019
Part 4: Pages 301-359. https://therebelpatient.substack.com/p/part-4-nih-coronavirus-disease-2019
This is the Updated Version that is Scheduled to be Scraped on August 16, 2024.
2024 Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
How to Cite the COVID-19 Treatment Guidelines:
COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/ Accessed [August 14, 2024.
The COVID-19 Treatment Guidelines Panel regularly updates the recommendations in these guidelines as new information on the management of COVID-19 becomes available. The most recent version of the guidelines can be found on the COVID-19 Treatment Guidelines website (https://www.covid19treatmentguidelines.nih.gov/)
Page 5:
What’s New In the Guidelines
Last Updated: February 29, 2024
In response to the rapidly evolving COVID-19 pandemic, the National Institutes of Health assembled a panel of experts to provide practical recommendations for health care providers and issued the first version of the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines on April 21, 2020. For close to 4 years, the COVID-19 Treatment Guidelines Panel (the Panel) has critically reviewed the growing body of research data on COVID-19 and used that information to develop and revise their recommendations for treating patients with this disease. The Panel has released a total of 72 versions of the Guidelines.
The federal COVID-19 Public Health Emergency ended in May 2023, and several professional societies currently provide COVID-19 treatment guidelines for their medical specialties or subspecialties.
Accordingly, this will be the final update of the COVID-19 Treatment Guidelines.
The Panel members hope these Guidelines have been of value to health care providers, and they appreciate the support and input they have received over the past 4 years.
The COVID-19 Treatment Guidelines website will remain available until August 16, 2024, and will provide a downloadable PDF of the final version of the Guidelines.
February 29, 2024
In preparation for this final version of the Guidelines, the Panel reviewed all the sections that were not updated on December 20, 2023. The information in these sections is current as of February 2024.
The Viral Rebound and Symptom Recurrence subsections in Therapeutic Management of Nonhospitalized Adults With COVID-19 and Ritonavir-Boosted Nirmatrelvir (Paxlovid) have been updated with new references. The Panel noted that concerns about the recurrence of symptoms or viral rebound should not be a reason to avoid using antiviral therapy when indicated.
The Panel updated the discussion on the role of remdesivir in adults with COVID-19 who require mechanical ventilation or extracorporeal membrane oxygenation in Therapeutic Management of Hospitalized Adults With COVID-19.
In Therapeutic Management of Nonhospitalized Children With COVID-19, the vaccination status categories that determine a child’s risk level for progression to severe disease have been changed from “Unvaccinated,” “Primary Series,” and “Up to Date” to “Not Up to Date” and “Up to Date.” Chronic kidney disease and pregnancy were added to the list of risk factors that are associated with progression to severe COVID-19.
Other sections that were reviewed for this final version of the Guidelines can be found in:
• Clinical Management of Adults
• Clinical Management of Children
• Antivirals, Including Antibody Products
If you made it all the way to the bottom, thank you for noting this document. I appreciate it, as I actually had a reader request that I unsubscribe them because they get too many emails from me. For this reason, I made this twice as long.
I also want to thank the new paid subscriber that balanced the above with faith in my work. It means more to me than you know. Thank you.
 | A guest post by
|
God bless yoUs ♥️🙏♥️
You are welcome! We have to help each other in actions and not lip service